Bullet Dodged: 2 High-Profile Stocks That Tanked This Year

Investors who passed up on the Canopy Growth stock and Aurora Cannabis stock are fortunate. Both high-profile names lost steam after a roaring start in 2021. The weed stocks remain speculative bets.

| More on:
Cannabis stocks have fallen.

The 2020 global pandemic opened buying opportunities in the TSX, with many high-profile stocks trading at deep discounts. While quite a number are delivering positive returns in 2021, a select few are tanking. You’re fortunate if you did not take positions in them yet, or you would have lost money as of this writing.

Canopy Growth (TSX:WEED)(NYSE:CGC) and Aurora Cannabis (TSX:ACB)(NYSE:ACB), industry leaders in the marijuana sector, seem ready for a breakout following the U.S. presidential elections in November 2020. However, both weed stocks are in a tailspin in late February 2021.

From heavy cannabis producer to a CPG company

Shares of Canopy Growth soared to $66.21 on February 10, 2021, only to slide 29% to $46.68 on February 22, 2021. Still, current investors are up 39% on optimism the federal legalization of marijuana in the U.S. will come soon.

Valuations of cannabis companies soared like crazy when Canada legalized in 2018. However, the sector’s boom did not happen, that it became unattractive ever since. The election of Joe Biden as the 46th President of the United States pushed weed stocks, including Canopy Growth, back in the limelight.

Key U.S. Senate leaders met with marijuana stakeholders in early February 2021. Senate Majority Leader Chuck Schumer, along with Senators Ron Wyden and Cory Booker, gathered feedback from various advocacy groups. After the discussions, the three senators plan to unveil draft reform legislation early this year.

Meanwhile, Canopy Growth laid off workers, shut down two massive greenhouses, and announced an $800 million write down in the next quarter. According to Canopy CEO David Klein, the company is right-sizing and improving financial performance.

For the largest shareholder, Constellation Brands, the sweeping overhaul should transform Canopy Growth from a startup, heavy cannabis producer to a basic stock standard consumer packaged goods CPG) company.

Cash burn concerns

Aurora Cannabis shares rose 21% to $23.96 on February 10, 2021, but have fallen since. As of February 22, 2021, the share price is down 38% to $14.83. However, current investors remain up by 40% year to date.

The $2.92 billion cannabis producer is struggling to reach the road to long-term profitability. In Q2 fiscal 2021 (quarter ended December 31, 2020), Aurora’s total net revenue increased by 23% to $67.6 million versus Q2 fiscal 2020. However, the net loss was a wider-than-expected $231 million. Notably, medical marijuana net revenue increased by 42%.

According to Aurora CEO Miguel Martin, the quarterly results were excellent. The initial rollouts of concentrates and vape products supported the core revenue strength in medical and consumer. However, many weed stocks are on fire in 2021 as Reddit traders that propelled GameStop are also moving to the cannabis space.

Some analysts worry about the continuing cash burn of Aurora. For now, the cannabis stock is speculative, and permanent gains are contingent on the full federal legalization of marijuana in the U.S. It might be better to sell the Aurora today before it tanks further.

Fragile sector

Canopy Growth and Aurora Cannabis are the leading weed stocks. However, they are not necessarily solid investment choices if you were to bet your money. The coming merger of Aphria and Tilray would create a powerhouse and the world’s largest cannabis company. It’s hard to pick a winner as the sector remains fragile.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »